Javier A. Villafuerte Gálvez
javiervg0902
For those interested in #Cdiff on 8/10, @SeresTX put out results of the phase 3 trial of SER-109 (oral microbial spore complex) for recurrent CDI (rCDI)press release: https://bit.ly/30WWZHt full NCT detail:
Read more